Stock Events

Stock Events

Search...

Summit Therapeutics (SMMT) Q2 2024 Earnings

1MayConfirmed

Q2 2023

Q3 2023

Q4 2023

Q2 2024

-0.06

-0.05

-0.03

-0.02

Details

Expected EPS

-0.06

Actual EPS

-0.06

Surprise EPS

0

Surprise Percent

+0%

Description

Summit Therapeutics (SMMT) has reported earnings of -0.06 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.